June 9, 2020 / 11:44 AM / a month ago

BRIEF-Immunic Announces FDA Allowance Of Its Phase 2, Calvid-1 Clinical Trial Of Imu-838 In Covid-19

June 9 (Reuters) - Immunic Inc:

* IMMUNIC, INC. ANNOUNCES U.S. FOOD AND DRUG ADMINISTRATION ALLOWANCE OF ITS PHASE 2, CALVID-1 CLINICAL TRIAL OF IMU-838 IN COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below